InspireMD, Inc.
NSPR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $7,009 | $6,205 | $5,171 | $4,495 |
| % Growth | 13% | 20% | 15% | – |
| Cost of Goods Sold | $5,503 | $4,398 | $4,054 | $3,741 |
| Gross Profit | $1,506 | $1,807 | $1,117 | $754 |
| % Margin | 21.5% | 29.1% | 21.6% | 16.8% |
| R&D Expenses | $13,634 | $7,981 | $7,810 | $5,158 |
| G&A Expenses | $15,306 | $11,104 | $8,356 | $7,405 |
| SG&A Expenses | $21,375 | $14,969 | $12,020 | $10,312 |
| Sales & Mktg Exp. | $6,069 | $3,865 | $3,664 | $2,907 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $35,009 | $22,950 | $19,830 | $15,470 |
| Operating Income | -$33,503 | -$21,143 | -$18,713 | -$14,716 |
| % Margin | -478% | -340.7% | -361.9% | -327.4% |
| Other Income/Exp. Net | $1,557 | $1,292 | $250 | -$157 |
| Pre-Tax Income | -$31,946 | -$19,851 | -$18,463 | -$14,873 |
| Tax Expense | $59 | $65 | $28 | $45 |
| Net Income | -$32,005 | -$19,916 | -$18,491 | -$14,918 |
| % Margin | -456.6% | -321% | -357.6% | -331.9% |
| EPS | -0.76 | -0.82 | -2.35 | -2.03 |
| % Growth | 7.3% | 65.1% | -15.8% | – |
| EPS Diluted | -0.76 | -0.82 | -2.35 | -2.03 |
| Weighted Avg Shares Out | 41,928 | 24,268 | 7,872 | 7,346 |
| Weighted Avg Shares Out Dil | 41,928 | 24,268 | 7,872 | 7,346 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,557 | $1,292 | $250 | $0 |
| Interest Expense | $0 | $0 | $0 | $157 |
| Depreciation & Amortization | $280 | $232 | $188 | $161 |
| EBITDA | -$33,223 | -$20,911 | -$18,525 | -$14,555 |
| % Margin | -474% | -337% | -358.2% | -323.8% |